Literature DB >> 16210343

Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster.

Silverio Perrotta1, Bruno Nobili, Marcella Ferraro, Carmela Migliaccio, Adriana Borriello, Valeria Cucciolla, Vincenzo Martinelli, Francesca Rossi, Francesca Punzo, Paola Cirillo, Giuseppe Parisi, Vincenzo Zappia, Bruno Rotoli, Fulvio Della Ragione.   

Abstract

Chuvash polycythemia (MIM 263400) is an autosomal recessive disorder characterized by a high hemoglobin level, relatively high serum erythropoietin, and early death. It results from a Von Hippel-Lindau (VHL) gene mutation (C598T) that causes increased HIF-1alpha activity and erythrocyte production in the face of normoxia. This polycythemia is endemic in Chuvashia, whereas its worldwide frequency is very low. We investigated the incidence of the Chuvash-type VHL mutation in Campania (South Italy) and identified 14 affected subjects (5 families). Twelve live on the island of Ischia (Bay of Naples). From analysis of the mutated allele, we found that the disease was more frequent on Ischia (0.070) than in Chuvashia (0.057). The haplotype of all patients matched that identified in the Chuvash cluster, thereby supporting the single-founder hypothesis. We also found that nonaffected heterozygotes had increased HIF-1alpha activity, which might confer a biochemical advantage for mutation maintenance. In conclusion, we have identified the first large cluster of Chuvash erythrocytosis outside Chuvashia, which suggests that this familial polycythemia might be endemic in other regions of the world.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210343     DOI: 10.1182/blood-2005-06-2422

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Clinical utility gene card for: familial erythrocytosis.

Authors:  Kais Hussein; Melanie Percy; Mary Frances McMullin
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 2.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 3.  Hypoxic regulation of erythropoiesis and iron metabolism.

Authors:  Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-05

4.  Oxygen sensing: recent insights from idiopathic erythrocytosis.

Authors:  Frank S Lee; Melanie J Percy; Mary Frances McMullin
Journal:  Cell Cycle       Date:  2006-05-01       Impact factor: 4.534

5.  Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha.

Authors:  Donghoon Yoon; David V Okhotin; Bumjun Kim; Yulia Okhotina; Daniel J Okhotin; Galina Y Miasnikova; Adelina I Sergueeva; Lydia A Polyakova; Alexei Maslow; Yonggu Lee; Gregg L Semenza; Josef T Prchal; Victor R Gordeuk
Journal:  J Mol Med (Berl)       Date:  2010-02-08       Impact factor: 4.599

6.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.

Authors:  Michele M Hickey; Jennifer C Lam; Natalie A Bezman; W Kimryn Rathmell; M Celeste Simon
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.

Authors:  Melanie J Percy; Paul W Furlow; Philip A Beer; Terence R J Lappin; Mary Frances McMullin; Frank S Lee
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

Review 8.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.

Authors:  Lucie Lanikova; Felipe Lorenzo; Chunzhang Yang; Hari Vankayalapati; Richard Drachtman; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

10.  Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range.

Authors:  Silverio Perrotta; Daniel P Stiehl; Francesca Punzo; Saverio Scianguetta; Adriana Borriello; Debora Bencivenga; Maddalena Casale; Bruno Nobili; Silvia Fasoli; Adriana Balduzzi; Lilla Cro; Katarzyna J Nytko; Roland H Wenger; Fulvio Della Ragione
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.